Form D Explorer

Form 1-K/A — 20/20 Biolabs, Inc.

0001213900-25-123375 · filed 2025-12-18

Offering

Total offering
—
Total sold
—
Security type
—
Price per security
—
Over-allotment
—
Jurisdictions
—

Issuer

Name
20/20 Biolabs, Inc.
CIK
1139685
Entity
Corporation
Jurisdiction
DE
Address
15810 GAITHER ROAD, SUITE 235
GAITHERSBURG, MD 20877

Most recent fiscal year financials

Reg A+ Tier 2 financials are audited (1-A, 1-K). Tier 1 are reviewed.

Total assets
—
Total liabilities
—
Cash
—
Total revenues
—
Net income
—

Same issuer's Form D filings

Same issuer's Reg CF (Form C) raises

View original on SEC EDGAR.